| Original language | English |
|---|---|
| Publication status | Published - 8 Nov 2014 |
| Event | ISPOR 17th Annual European Congress 2014: New challenges for improving European health care - Amsterdam RAI, Amsterdam, Netherlands Duration: 8 Nov 2014 → 12 Nov 2014 |
Conference
| Conference | ISPOR 17th Annual European Congress 2014 |
|---|---|
| Abbreviated title | ISPOR |
| Country | Netherlands |
| City | Amsterdam |
| Period | 8/11/14 → 12/11/14 |
Keywords
- METIS-306280
- IR-92434
Cite this
Kip, M. M. A., Bosch, M., Fischer, K., Tamminga, R. Y. J., & Lepage-Nefkens, I. (2014). Cost-effectiveness analysis evaluating Factor VIII as primary prophylaxis treatment for patients with severe haemophilia A in The Netherlands. Paper presented at ISPOR 17th Annual European Congress 2014, Amsterdam, Netherlands.
@conference{30b2fe2bb17c48868fc40a14ef774757,
title = "Cost-effectiveness analysis evaluating Factor VIII as primary prophylaxis treatment for patients with severe haemophilia A in The Netherlands",
keywords = "METIS-306280, IR-92434",
author = "Kip, {Michelle Maria Aleida} and M. Bosch and K. Fischer and R.Y.J. Tamminga and I. Lepage-Nefkens",
year = "2014",
month = "11",
day = "8",
language = "English",
note = "ISPOR 17th Annual European Congress 2014 : New challenges for improving European health care, ISPOR ; Conference date: 08-11-2014 Through 12-11-2014",
}
Kip, MMA, Bosch, M, Fischer, K, Tamminga, RYJ & Lepage-Nefkens, I 2014, 'Cost-effectiveness analysis evaluating Factor VIII as primary prophylaxis treatment for patients with severe haemophilia A in The Netherlands' Paper presented at ISPOR 17th Annual European Congress 2014, Amsterdam, Netherlands, 8/11/14 - 12/11/14, .
Cost-effectiveness analysis evaluating Factor VIII as primary prophylaxis treatment for patients with severe haemophilia A in The Netherlands. / Kip, Michelle Maria Aleida; Bosch, M.; Fischer, K.; Tamminga, R.Y.J.; Lepage-Nefkens, I.
2014. Paper presented at ISPOR 17th Annual European Congress 2014, Amsterdam, Netherlands.Research output: Contribution to conference › Paper
TY - CONF
T1 - Cost-effectiveness analysis evaluating Factor VIII as primary prophylaxis treatment for patients with severe haemophilia A in The Netherlands
AU - Kip, Michelle Maria Aleida
AU - Bosch, M.
AU - Fischer, K.
AU - Tamminga, R.Y.J.
AU - Lepage-Nefkens, I.
PY - 2014/11/8
Y1 - 2014/11/8
KW - METIS-306280
KW - IR-92434
M3 - Paper
ER -
Kip MMA, Bosch M, Fischer K, Tamminga RYJ, Lepage-Nefkens I. Cost-effectiveness analysis evaluating Factor VIII as primary prophylaxis treatment for patients with severe haemophilia A in The Netherlands. 2014. Paper presented at ISPOR 17th Annual European Congress 2014, Amsterdam, Netherlands.